The purpose of this study is to investigate if playing a newly developed videogame that requires physical activity (e.g. exergame), leads to increased physical activity and health benefits in children and adolescents who do not regularly participate in endurance training. Health benefits will be expressed in physical fitness (maximal oxygen consumption), blood markers of a healthy heart, body composition and objectively measured physical activity. Gaming frequency of the participants will be registered throughout the 24 week intervention period.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Enrollment
29
free access to the exergaming platform PlayPulse for 24 weeks
Department of Circulation and Medical Imaging
Trondheim, Norway
VO2max
Maximal Aerobic Capacity
Time frame: 12 weeks
VO2max
Maximal Aerobic Capacity
Time frame: 24 weeks
Change in daily average energy expenditure
Measured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period, 12 weeks and 24 weeks.
Time frame: Baseline, 12 and 24 weeks
Change in daily time in sedentary activity (<3.0 metabolic equivalents =METs)
Measured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period, 12 weeks and 24 weeks.
Time frame: Baseline, 12 and 24 weeks
Change in daily time in moderate intensity activity (3.0-6.0 metabolic equivalents = METs)
Measured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period, 12 weeks and 24 weeks.
Time frame: Baseline, 12 and 24 weeks
Change in daily time in vigorous intensity activity (6.0-9.0 metabolic equivalents = METs)
Measured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period, 12 weeks and 24 weeks.
Time frame: Baseline, 12 and 24 weeks
Change in daily time in very vigorous intensity activity (>9.0 metabolic equivalents = METs)
Measured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period, 12 weeks and 24 weeks.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: Baseline, 12 and 24 weeks
Change in daily average total physical activity duration
Measured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period, 12 weeks and 24 weeks.
Time frame: Baseline, 12 and 24 weeks
Change in daily average number of steps
Measured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period, 12 weeks and 24 weeks.
Time frame: Baseline, 12 and 24 weeks
Bioelectrical impedance
Body composition assessed using bioelectrical impedance analysis (InBody 720)
Time frame: 12 and 24 weeks
systolic Blood Pressure
Time frame: 12 and 24 weeks
Diastolic Blood Pressure
Time frame: 12 and 24 weeks
Fasting circulating glucose, as blood marker of cardiometabolic health
Time frame: 24 weeks
Lipid profile, as blood marker of cardiometabolic health
Time frame: 24 weeks
Circulating insulin concentration, as blood marker of cardiometabolic health
Time frame: 24 weeks
HbA1c from blood samples
Time frame: 24 weeks